News
PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...
Lawmakers question Kennedy on staffing cuts, funding freezes and policy changes at health department
Democrats and Republicans alike raised concerns on Wednesday about deep staffing cuts, funding freezes and far-reaching ...
The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled study. It is designed to evaluate the relative efficacy, safety, and immunogenicity of Vaxart's oral COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback